Development and validation of a machine-learning model to predict 1 bone marrow fibrois from complete blood count in 2 myeloproliferative neoplasms (FIBOM-AI): a multicentre study
Marie Donzel(Hospices Civils de Lyon), Vincent Alcazer(Lyon 1 Université), Jean‐Christophe Ianotto(Inserm), Luojun Wang(Xijing Hospital), Marion Eveillard(Nantes Université), Laurent Jallades(Université Claude Bernard Lyon 1), Olivier Mansier(Target (United States)), Fiorenza Barraco(Hôpital Lyon Sud), Elsa Poullot(Assistance Publique – Hôpitaux de Paris), Simon Chevalier(Centre Hospitalier Universitaire de Grenoble), Charlotte Syrykh(Institut universitaire du cancer de Toulouse Oncopole), Véronique Meignin(Saint Louis University Hospital), Louis Drevon(Assistance Publique – Hôpitaux de Paris), Simona Pagliuca(Centre Hospitalier Régional et Universitaire de Nancy), Laurence Legros(Hôpital l'Archet), Véronique Demas, Mathias Brehon(Hôpital Lyon Sud), Éric Lippert(Inserm), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Barbara Burroni(Hôpital Cochin), Nelly Bosselut(Assistance Publique – Hôpitaux de Paris), Nicolas Freynet(Assistance Publique – Hôpitaux de Paris), Pascale Flandrin‐Gresta(Hôpital Nord), Suzanne Tavitian(Institut universitaire du cancer de Toulouse Oncopole), Xavier Hittinger(Nantes Université), Christopher Aubert(Centre Hospitalier Régional et Universitaire de Nancy), Sarah Zouaghi(Hôpital Lyon Sud), Agathe Gouband(Centre Hospitalier Universitaire d'Angers), Seddig MOMENKHAN(Hôpital Lyon Sud), Syrine KHEDIMALLAH(Centre Hospitalier Universitaire de Grenoble), M Meunier, Nursemin Yilmaz(Assistance Publique – Hôpitaux de Paris), Cyrus Hsia(London Health Sciences Centre), Benjamin Chin-Yee(London Health Sciences Centre), Marie Parrens, Silvia Maria Bezsera, Sabrina Barriere, Damien Luquepaz, Pierre Sujobert, Alexandra Traverse-Glehen, Lydia Roy(Centre Hospitalier Universitaire de Poitiers), Hélène Labussière-Wallet, Lila Gilis(Hospices Civils de Lyon)
HAL (Le Centre pour la Communication Scientifique Directe)
January 1, 2026
Cited by 0
Related Papers
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
|New England Journal of Medicine|2010|385
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
|Leukemia|2008|354
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309